HENDERSON, Nev., March 11, 2025 /PRNewswire/ --VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces first patient enrollment in a clinical study ...
HENDERSON, Nev., March 13, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the expansion of its Nu.Q® Vet Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback